Aviva Meditech Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 0.50 M
as on 16-06-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -87.58%
(FY 2023)
- Profit -14.28%
(FY 2023)
- Ebitda -2.64%
(FY 2023)
- Net Worth -92.78%
(FY 2023)
- Total Assets -2.43%
(FY 2023)
About Aviva Meditech
The Corporate was formerly known as Aviva Technologies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Manav Vijan and Rajkumar Vijan serve as directors at the Company.
- CIN/LLPIN
U33100GJ2019PTC106927
- Company No.
106927
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Umbergaon, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aviva Meditech Private Limited offer?
Aviva Meditech Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Pain Relief Drugs & Pharmaceuticals, Pain Reliever Gel.
Who are the key members and board of directors at Aviva Meditech?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajkumar Vijan | Director | 05-Mar-2019 | Current |
Manav Vijan | Director | 04-Dec-2021 | Current |
Financial Performance of Aviva Meditech.
Aviva Meditech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 87.58% decrease. The company also saw a substantial fall in profitability, with a 14.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 92.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Aviva Meditech?
In 2023, Aviva Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aviva Meditech?
Unlock and access historical data on people associated with Aviva Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aviva Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aviva Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.